TMOON
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Nume TMOON
Poziție No.3562
Capitalizare de piață $0.00
Capitalizare de piață complet diluată $0.00
Cotă de piață %
Volum de tranzacționare/capitalizare de piață (24 h) 5,859,075.83%
Ofertă află în circulație 11.23535994
Ofertă maximă 0
Ofertă totală 11.23535994
Rată de circulație %
Data emiterii --
Prețul la care activul a fost emis pentru prima dată --
Maxim dintotdeauna 643.187233444486, 2026-01-22
Cel mai mic preț 437.1989421522778, 2026-05-18
Lanț de blocuri public TMOON
Introducere Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Sector
Rețele sociale
Analiza fluxului de fonduri
|
Cumpără(TMOON) |
Vinde(TMOON) |
Credit net |
| Mare |
-- |
-- |
-- |
| Mediu |
-- |
-- |
-- |
| Mic |
-- |
-- |
-- |
| Total |
-- |
-- |
-- |
etfindex:mc_etfindex_source Declarație de declinare a responsabilității: Datele sunt furnizate de cmc și nu trebuie considerate drept consultanță pentru investiții.
